Headline
The latest stories from AHA Today.
The Department of Health and Human Services and other federal agencies today proposed delaying the general compliance date for 2018 requirements under the Common Rule to Jan. 21, 2019, which would give covered entities six additional months to implement the requirements.
Thirteen states participating in a regional collaborative to improve birth outcomes in the South decreased early elective deliveries by an average 22% between 2011 and 2014, compared with 14% in other regions.
As Virginia leaders work to find a state budget compromise that includes a health care coverage access plan, the Virginia Hospital & Healthcare Association and 30 other organizations representing health care providers yesterday issued a joint statement encouraging and supporting expanded access…
The Senate Finance Committee today held a hearing on “tackling opioid and substance use disorders in Medicare, Medicaid and human services programs.”
The number of U.S. retail opioid prescriptions fell by 10.2% in 2017, including a 16.1% decline in high-dose prescriptions, according to a report released today by the IQVIA Institute for Human Data Science.
The Department of Health and Human Services yesterday awarded $485 million in grants to help states and territories combat the opioid crisis, the last of two funding rounds provided for in the 21st Century Cures Act.
Health and Human Services Secretary Alex Azar yesterday named Indiana insurance executive James Parker to direct the HHS Office of Health Reform and lead the department’s initiative to make health insurance more affordable and available.
Health care providers should not use endoscope connectors labeled for use without reprocessing between patients because they carry a risk of cross-contamination, the Food and Drug Administration announced today.
Sen. Elizabeth Warren (D-MA) and Rep. Elijah Cummings (D-MD) today introduced the Comprehensive Addiction Resources Emergency Act, legislation that would provide $100 billion in federal funding over 10 years to help states and communities address the opioid crisis.
Sixteen U.S. senators today urged the Department of Health and Human Services to take immediate action to reduce the price of naloxone – a drug that can be delivered via nasal mist or injection to temporarily suspend the effects of an overdose until emergency responders arrive.